Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: xcr600 who wrote (11590)	4/15/2003 6:15:23 PM
From: Bucky Katt	Respond to of 48461

I am sure that really pisses off the French, which makes it ok with me. The key for us is how to profit from it..This is a spoil of war.. Anyone remember when I bought the dump on HAL when it got sold out into $9? I should have kept those shares.. Any ideas, folks??

To: xcr600 who wrote (11590)	4/16/2003 8:25:56 AM
From: Dale Baker	Read Replies (2) \| Respond to of 48461

Think about all the billions that will pour into Iraq instead of your local police department, fire department, emergency preparedness system, hospitals, etc.......

To: xcr600 who wrote (11590)	4/16/2003 8:28:07 AM
From: RockyBalboa	Read Replies (3) \| Respond to of 48461

SARS.....CBMX! CombiMatrix Announces First SARS Virus Microarray Tuesday April 15, 9:08 pm ET NEWPORT BEACH, Calif.--(BUSINESS WIRE)--April 15, 2003--Acacia Research Corporation (Nasdaq:ACTG - News; Nasdaq:CBMX - News) announced today that CombiMatrix has designed and fabricated the first microarray based on the SARS (Severe Acute Respiratory Syndrome) coronavirus genome published earlier this week. The first microarrays were fabricated within 48 hours of publication of the coronavirus genome sequence believed to be responsible for SARS, underscoring CombiMatrix' ability to rapidly design and build custom microarrays. biz.yahoo.com